Equitable Trust CO Amgen Inc Transaction History

Equitable Trust CO

$1.37 Billion
Q2 2024

A detailed history of Equitable Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Equitable Trust CO holds 21,270 shares of AMGN stock, worth $7.07 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

21,270

Previous 19,073 11.52%

Holding current value

$7.07 Million

Previous $5.42 Million 22.56%

% of portfolio

0.48%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $577,261 - $701,524	2,197 Added 11.52%	21,270 $6.65 Million
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $1.86 Million - $2.24 Million	6,900 Added 56.68%	19,073 $5.42 Million
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $2.57 Million - $2.9 Million	10,064 Added 477.19%	12,173 $3.51 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $15,961 - $19,816	73 Added 3.59%	2,109 $566,000
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $26,191 - $31,923	-116 Reduced 5.39%	2,036 $492,000
Q4 2022 Feb 21, 2023	BUY	$229.03 - $291.01 $54,738 - $69,551	239 Added 12.49%	2,152 $565,000
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $25,608 - $28,498	111 Added 6.16%	1,913 $465,000
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $2,631 - $2,910	-12 Reduced 0.66%	1,802 $436,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $795 - $910	4 Added 0.22%	1,814 $408,000
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $964,342 - $1.13 Million	-4,543 Reduced 71.51%	1,810 $385,000
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $96,001 - $106,506	-411 Reduced 6.08%	6,353 $1.55 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $119,387 - $139,126	538 Added 8.64%	6,764 $1.68 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $74,218 - $88,380	343 Added 5.83%	6,226 $1.43 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $5,631 - $6,262	24 Added 0.41%	5,883 $1.5 Million
Q1 2020 May 21, 2020	BUY	$182.24 - $241.7 $692,329 - $918,218	3,799 Added 184.42%	5,859 $1.19 Million
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $24,975 - $32,102	132 Added 6.85%	2,060 $497,000
Q3 2019 Nov 19, 2019	BUY	$174.11 - $208.62 $43,005 - $51,529	247 Added 14.69%	1,928 $373,000
Q2 2019 Aug 16, 2019	SELL	$166.7 - $195.41 $21,504 - $25,207	-129 Reduced 7.13%	1,681 $309,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $73,433 - $82,775	406 Added 28.92%	1,810 $343,000
Q4 2018 Feb 22, 2019	SELL	$178.4 - $208.25 $7,314 - $8,538	-41 Reduced 2.84%	1,404 $274,000
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $414,123 - $466,869	-2,235 Reduced 60.73%	1,445 $299,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $611,064 - $686,356	3,680 New	3,680 $680,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Amgen Inc Transaction History